- Home
- FGI vs SNGX Comparison
FGI vs SNGX Comparison
Compare FGI & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- SNGX
- Stock Information
- Founded
- FGI 1987
- SNGX 1987
- Country
- FGI United States
- SNGX United States
- Employees
- FGI N/A
- SNGX 15
- Industry
- FGI Industrial Specialties
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- SNGX Health Care
- Exchange
- FGI Nasdaq
- SNGX Nasdaq
- Market Cap
- FGI 9.4M
- SNGX 7.4M
- IPO Year
- FGI 2022
- SNGX 1987
- Fundamental
- Price
- FGI $0.80
- SNGX $2.85
- Analyst Decision
- FGI
- SNGX
- Analyst Count
- FGI 0
- SNGX 0
- Target Price
- FGI N/A
- SNGX N/A
- AVG Volume (30 Days)
- FGI 10.0K
- SNGX 49.3K
- Earning Date
- FGI 11-11-2024
- SNGX 11-08-2024
- Dividend Yield
- FGI N/A
- SNGX N/A
- EPS Growth
- FGI N/A
- SNGX N/A
- EPS
- FGI N/A
- SNGX N/A
- Revenue
- FGI $127,180,460.00
- SNGX $364,183.00
- Revenue This Year
- FGI $11.39
- SNGX N/A
- Revenue Next Year
- FGI $6.26
- SNGX $76.64
- P/E Ratio
- FGI N/A
- SNGX N/A
- Revenue Growth
- FGI 7.71
- SNGX N/A
- 52 Week Low
- FGI $0.70
- SNGX $1.83
- 52 Week High
- FGI $1.85
- SNGX $19.20
- Technical
- Relative Strength Index (RSI)
- FGI 45.90
- SNGX 33.88
- Support Level
- FGI $0.75
- SNGX $2.93
- Resistance Level
- FGI $0.89
- SNGX $3.32
- Average True Range (ATR)
- FGI 0.05
- SNGX 0.20
- MACD
- FGI 0.00
- SNGX -0.03
- Stochastic Oscillator
- FGI 35.71
- SNGX 0.00
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).